What is BioSkin?
BioSkin is a family-owned enterprise with a 25-year legacy in crafting premium sports medicine and orthopedic bracing solutions. Serving professional sports teams, orthopedic clinics, and active individuals globally, BioSkin is dedicated to enhancing lives by aiding recovery from pain and injury. The company distinguishes itself through continuous innovation, developing sophisticated bracing technologies that leverage a deep understanding of human anatomy and physiology to provide optimal support and stability. This commitment to design excellence and customer feedback has cemented its reputation in a competitive landscape, with a clear objective to help individuals regain their desired activity levels.
How much funding has BioSkin raised?
BioSkin has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in BioSkin
PPP
Public-Private Partnership
What's next for BioSkin?
With the recent influx of $350K in strategic investment, BioSkin is poised for accelerated growth and further product development. This substantial capital injection, part of its $350K overall financing, suggests a focus on scaling operations, expanding market reach, and potentially investing in research and development for next-generation orthopedic and sports medicine technologies. The company's late-stage funding context implies a strategic push towards market leadership and sustained innovation in helping individuals overcome physical limitations.
See full BioSkin company page
